The Psycholytic Treatment of a Childhood Schizophrenic Girl

Fisher, Gary

doi:10.1177/002076407001600204

Cited by 14 publications

(17 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Probabl y one of the most fascinating articles in the lit erature is the case study published by Fisher (1970). .…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

“…The study had to be terminated prematurely due to legal restraints that came to be placed un the use of the drugs in the early 1960's, and no final report was ever published. Consequently the o nly information available on the study is contained in an unpublished interim report (Fisher & Castille 1963), which is partially described in Mogar and Aldrich (1969), and Fisher's ca se study (Fisher 1970).…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

“…Her development had been slow and marked by hospitalization and repeated evaluations, during the course of which she received "a variety of diagnoses including CNS pathology, childhood schizophrenia, mental retardation, severe emotional disturbance and severe brain injury from birth." (Fisher 1970). Likewise her behavior had been described as "biza rre, grossly regressive, retarded , hyperactive , assaultive, erratic an d destructive."…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

“…Likewise her behavior had been described as "biza rre, grossly regressive, retarded , hyperactive , assaultive, erratic an d destructive." (Fisher 1970). At the time she was evaluated for treatment with psychedelics, after a number of drugs and ten ECT (electro-convulsive therapy) treatments had produced no improvement, she was described in the following manner:…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

“…Her typical day was spent sitting in a .Io urnal of Psychedelic J)mgs 96 TREATMENT OF DISTURBED CHILDREN corner of the ward with two major activities, one was protecting herself from the assaults of other children and the sec ond was twirling bits of paper in her long fingers , constantly rocking herself, masturbating and talking wo rd-s alad almost incessantly." (Fisher 1970). She was given a total of thirteen treatment sessions using LSD (in a dose range from 100 to 300 /lg), two treatment sessions using psilocybin (l0 mg once and 30 mg once), and one treatment session combining the two (200 /lg LSD and 10 mg psilocybin).…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

See 4 more Smart Citations

The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review

Rhead¹

1977

Journal of Psychedelic Drugs

View full text Add to dashboard Cite

“…Probabl y one of the most fascinating articles in the lit erature is the case study published by Fisher (1970). .…”

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

Section: Joumal Nf Psychedelic Drugs 95mentioning

confidence: 99%

See 3 more Smart Citations

The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review

Rhead¹

1977

Journal of Psychedelic Drugs

View full text Add to dashboard Cite

Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults

Danforth¹

2021

Disruptive Psychopharmacology

View full text Add to dashboard Cite

The possible place for psychedelics in pharmacotherapy of mental disorders

Wojtas

2023

Pharmacol. Rep

View full text Add to dashboard Cite

Since its emergence in the 1960s, the serotonergic theory of depression bore fruit in the discovery of a plethora of antidepressant drugs affecting the lives of millions of patients. While crucial in the history of drug development, recent studies undermine the effectiveness of currently used antidepressant drugs in comparison to placebo, emphasizing the long time it takes to initiate the therapeutic response and numerous adverse effects. Thus, the scope of contemporary pharmacological research shifts from drugs affecting the serotonin system to rapid-acting antidepressant drugs. The prototypical representative of the aforementioned class is ketamine, an NMDA receptor antagonist capable of alleviating the symptoms of depression shortly after the drug administration. This discovery led to a paradigm shift, focusing on amino-acidic neurotransmitters and growth factors. Alas, the drug is not perfect, as its therapeutic effect diminishes circa 2 weeks after administration. Furthermore, it is not devoid of some severe side effects. However, there seems to be another, more efficient, and safer way to target the glutamatergic system. Hallucinogenic agonists of the 5-HT2A receptor, commonly known as psychedelics, are nowadays being reconsidered in clinical practice, shedding their infamous 1970s stigma. More and more clinical studies prove their clinical efficacy and rapid onset after a single administration while bearing fewer side effects. This review focuses on the current state-of-the-art literature and most recent clinical studies concerning the use of psychedelic drugs in the treatment of mental disorders. Specifically, the antidepressant potential of LSD, psilocybin, DMT, and 5-MeO-DMT will be discussed, together with a brief summary of other possible applications.

show abstract

The Psycholytic Treatment of a Childhood Schizophrenic Girl

Cited by 14 publications

References 3 publications

The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review

The Use of Psychedelic Drugs in the Treatment of Severely Disturbed Children: A Review

Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults

The possible place for psychedelics in pharmacotherapy of mental disorders

Contact Info

Product

Resources

About